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Abstract.  From merely being cod liver oil taken for vitamins A and D, fish oils have moved into the center stage of fatty acids in 
nutrition.  The analytical work starting in 1950 provided the means to recognize the long-chain and truly essential n-3 
polyunsaturated fatty acids vital for retinal, neurological and cellular membrane functions in our bodies.  The AEskimo@ studies 
of twenty years ago have also now been followed scientifically for two decades, into our recognizing fish and shellfish as highly 
desirable food sources of these n-3 fatty acids for cardiovascular benefits. 
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1 INTRODUCTION 
 
The folklore about fish being a brain food was imparted to me 
about 1934 by my maternal grandmother.  As always, she was 
right.  I have been able to trace this saying to the middle of the 
19
th century, when organic solvents became available and 
German scientists were able to extract things like cod fish 
muscle and human brains.  The grey pastes that resulted from 
these two materials were rather similar, since they were 
dominated by phospholipids with a substantial proportion of 
highly unsaturated fatty acids, both materials not yet known to 
science. 
 
Fish oils were used as industrial chemicals for a hundred years 
though they were not understood in detail.  Their uses were 
partly based on paints and linoleum, materials where the fatty 
acids we now know to be highly unsaturated could crosslink 
into polymers.  Hydrogenation for margarine was possible 
from about 1900, but the quality and purity of the raw material 
was dubious.  Sulphur compounds, for example, from the 
amino acids of fish protein left too long before oil production, 
poisoned the catalysts.  At the time whale oil was preferred as 
it was a purer raw material, and even as late as 30 years ago 
seal oil commanded a higher price than fish oil in Canada for 
margarine and shortening manufacture because of quality and 
ease of manufacture.  Today we know that this procedure 
applied to marine oils was wasting highly unsaturated fatty 
acids potentially valuable in our diets.   
 
In 1952 Bailey, Carter and Swain published Bulletin 89 of the 
Fisheries Research Board of Canada.  By this time common 
terrestrial fatty acids such as oleic, linoleic and alpha-linolenic 
had definite structures and could be discussed for foods, but 
the long-chain, highly unsaturated fatty acids of marine origin 
were listed under a variety of names (usually related to the 
species of fish providing the oil that was examined) and an 
even greater assortment of positions for the ethylenic bonds. 
 
Two teams resolved most of the significant issues.  E. Klenk, 
in Germany, published a series of papers in 1958-1962 
accurately defining several marine polyunsaturated fatty acids 
such as all-cis-6,9,12,15-octadecatetraenoic fatty acid (18:4n-
3, now called stearidonic).  The rapid implementation of 
chromatographic technology, especially thin-layer and gas-
liquid chromatography, and adequate funding by the 
Rockefeller Institute, led to a group there publishing an almost 
complete analysis of the fatty acids of menhaden oil (Farquhar 
et al., 1959).  The conceptual problem in identifications was 
that everybody tried to relate these through the positions of the 
ethylenic bonds relative to the carboxyl group.   
 
By 1962 H.J. Thomasson had realized the importance of the 
other end of the chain (Thomasson, 1962) and with this useful 
addition most of the work of the biochemistry group of the 
Hormel Institute and elsewhere on ’essential fatty acids’ fell 
into place.  Personally I benefitted enormously from 
publications of these authors because Halifax, Nova Scotia, 
Canada, was remote from other centres doing research into 
highly unsaturated animal and marine fatty acids.  Standards 
were scarce and expensive.  With the data available I was able 
to organise almost all polyunsaturated fatty acids of marine 
organisms into structural groups, thus easily identifying 
unknown peaks in one analysis on any GLC column.   
 
For example separation factors for ethylenic bonds could be 
generated from the almost any readily available vegetable oil: 
 
     relative   separation factors 
Structure ˜  position  retention 
       time  3/6  6/9  3/9 
 
18:3n-3  9,12,15     1.76  -  -  - 
18:2n-6  9,12     1.35  1.30  -  - 
18:1n-9  9     1.12  -  1.21  1.57 
 
In my GLC runs of marine lipid fatty acids a large peak at the 
end was sure to be docosahexaenoic acid, so one could look 
for obvious peaks eluting earlier based on the above factors  IIFET 2000 Proceedings 
 
  2 
from the vegetable oil analysis on the same column. In this 
case: 
 
22:6n-3  4,7,10,13,16,19     9.55  -  -  - 
22:5n-6  4,7,10,13,16     7.43  1.28  -  - 
(22:4n-9)  (4,7,10,13)    (6.17)  -  1.21  1.55 
 
No peak could be found near the predicted 22:4n-9 position in 
the methyl esters of fish oil fatty acids so probably it would not 
exist.  A peak observed adjacent to and before 22:6n-3 (DHA, 
docosahexaenoic acid) was probably 22:5n-3 (DPA, 
docosapentaenoic acid).  From it 22:4n-6 could be predicted 
by the same procedure, and the obvious 20:5n-3 (EPA, 
eicosapentaenoic acid) peak predicted 20:4n-6, arachidonic 
acid, and 20:3n-9, observed in cases of essential fatty acid 
deficiency in mammals and called Mead acid.  The process 
could also be reversed, for example from 20:1n-9 one could 
predict where 20:2n-6 and 20:3n-3 would be found. 
 
The same retention data could be plotted graphically as 
parallel line systems on semi-log paper, permitting 
identification between chain lengths for fatty acids of different 
numbers of carbon atoms and the same number of ethylenic 
bonds, for each of the n-3, n-6 or n-9 structures.  These two 
technologies were published in 1963 (Ackman 1963a; 1963b). 
 In general terms the various fish oil monoethylenic isomers 
could be grouped together by plotting as n-11, n-9, n-7 and 
even n-5. 
 
The overall result was the identification of the fatty acids 
shown in Figure 1, including the exotic n-1, n-4, n-7 series of 
polyunsaturated fatty acids of algal origin identified by Klenk 
and colleagues in herring and in menhaden oil by the 
Rockefeller team.  Figure 2 shows the importance of these fatty 
acids in algae and their lesser importance in menhaden oil. 
 
By 1966 we had capillary GLC capability and the structurally 
novel monoethylenic fatty acids of Figure 1 could be readily 
identified.  Ironically about that time (1964) in Great Britain 
Hilditch and Williams published a book, "The Chemical 
Constitution of Natural Fats" which is known to many of you.  
It was the first book to explain the chemistry of most fats and 
oils in terms of specific fatty acids.  Unfortunately fish oils in 
nutrition were not widely understood or examined as foods 
except as sources of vitamins A and D.  M.E. Stansby 
benefitted from the output of the Saltenstall-Kennedy program 
that funded much fish oil biochemical and nutritional research 
to edit a new and very useful book on the subject (Stansby, 
1967). 
 
At the same time the cholesterol dogma began to terrify the 
population of western society and the edible oils industry used 
the benefits of linoleic acid in lowering serum cholesterol to 
push vegetable oils such as corn and soybean into the 
marketplace.  In Canada, Health and Welfare Canada refused 
to put the newly developed canola oil on a list of 
recommended edible oils because it had only 20% of linoleic 
acid.  They did not regard the accompanying 10% of alpha-
linolenic acid as useful or essential in any way.  This type of 
mental block was the basis of the extraordinary delay in any 
type of n-3 fatty acid achieving recognition as "essential" 
(Holman 1998) and it persists to this day in current approved 
labelling of foods. 
 
Although I have not mentioned saturated fatty acids, in marine 
oils and fats the even-carbon series 14:0-16:0-18:0 
predominate, with minor amounts of 15:0 and 17:0, and of iso 
and anteiso C15 and C17 chain lengths.  These total 15-30%.  
All of the saturated acids can be biosynthesized by any fish or 
shellfish, and this is also true of 16:1n-7 and 18:1n-9, both 
originating in a ˜9 desaturase operating on 16:0 or 18:0 
respectively.  Many fish oils have some elongation of 16:1n-7 
to 18:1n-7, the latter usually being about a quarter of the 
18:1n-9 isomer.  The 20:1 fatty acids are to some extent 
created by elongation of the two 18:1 isomers but with 
capillary GLC a small proportion of 20:1n-11 is often seen 
accompanying 20:1n-9 and 20:1n-7.  The 22:1 monoethylenic 
fatty acids have a mainly different origin, in the wax esters of 
copepods (Ratnayake and Ackman 1979a;1979b).  For 
unknown reasons the structure of the principal fatty alcohol of 
many copepods may be 22:1n-11, and this is converted to the 
corresponding fatty acid in the gut mucosa of predatory fish 
such as capelin, herring or mackerel.  Some 22:1n-9 and even 
22:1n-7 may be present, probably originating in the C18 and 
C20 monoethylenic isomers.  Table 1 compares 14 fatty acids 
of menhaden oil with those of herring oil, and of the fatty acids 
of muscle phospholipids from farmed Atlantic salmon and 
Atlantic cod.   
 
Certain generalities are apparent.  In the fish body oils 
saturated acids are variable, and the proportions are inversely 
related to 20:1 and 22:1.  A range of 20-35% is a reasonable 
expectation.  In the two oils of Table 1 EPA exceeds DPA, 
although in other fish body oils such as those of pelagic tuna 
the proportions are often 5% EPA accompanied by as much as 
20% DHA.  The range for the total of these two highly 
unsaturated fatty acids in common fish oils is about 13-25 %.  
Winterizing menhaden oil leads to removal of triacylglycerols 
rich in saturated fatty acids and total EPA and DHA can then 
be pushed to 30%. 
 
The two phospholipids contain about 22%-25% saturated acids 
and 16-26% monoethylenic acids.  The salmon were fed a diet 
rich in herring oil, accounting for the 8% total for 20:1 and 
22:1 in the muscle phospholipids.  Usually these are less 
important in phospholipids and a figure of 2% is more typical. 
 Arachidonic acid (20:4n-6) is not well represented in these 
cold-water marine species.  As little as 1-2% of 18:2n-6 is IIFET 2000 Proceedings 
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found in these oils (not shown) and a similar amount of 18:3n-
3 would be found in the phospholipids.  The important items in 
human nutrition are the highly unsaturated fatty acids EPA and 
DHA, usually totalling around 40% of the fatty acids of fish 
phospholipids. 
 
The question most asked about omega-3 fatty acids in fish is 
the wrong question.  Invariably somebody wants the 
percentages in the total fatty acids.  This is part of the numbers 
game in selling a product.  What they should really ask for is 
the g/100 g figure for edible parts.  Fortuitously, for most 
marine fish, muscle will contain about 0.8% phospholipids.   
The phospholipid in 100 g of edible muscle may contain 
approximately 75% or 0.6 g of fatty acids, so the available 
EPA and DHA from that source will be about 40% of that or 
240 mg.  Most one-gram fish oil capsules contain 150-300 mg 
total omega-3 fatty acids so one serving of lean fish equates 
with one fish oil capsule. 
 
Supposing a salmon fillet with 11% extractable fat is served, 
then of this approximately 0.8 g will be phospholipids and 10.2 
g will be triglycerides.  Using the figures in Table 1 these will 
contain the same muscle phospholipids (18:4n-3 + 20:5n-3 + 
22:5n-3 + 22:6n-3 = 43.6%), supplying 260 mg per 100 g of 
salmon muscle.  Salmon oil is not especially high in these fatty 
acids, but the 10 g of matching triacylglycerols (Polvi et al, 
1992) will have (1.3 + 2.5 + 1.0 + 5.5 = 10.3%) of omega-3 
fatty acids, so the oil supplies nearly 1 gram of additional 
omega-3 fatty acids per 100 g, for a total of 1.26 g.  Assuming 
no loss of oil on cooking, a serving of "oily" salmon will 
contain much more omega-3 fatty acids than are provided by 
several ordinary fish oil capsules.  That is why a Government 
committee recommendation in Great Britain was to eat fish at 
least twice a week, and of these one serving should be of oily 
fish (U.K. Department of Health 1994). 
 
 
2. Freshwater  Fish 
 
Most of the fish in North America￿s lakes and rivers are 
descendants of sea fish that recolonized these waters after 
glaciations.  Some, like salmon, spawn in freshwater and return 
to the sea, and some, like arctic char, reverse the process.   
Basically they therefore share the same fatty acids except for a 
little more emphasis on the n-6 fatty acids when in freshwater.  
In marine fish n-6 fatty acids these may total only 3-5%, but in 
purely freshwater fish it could be 5-10%.  There are still plenty 
of n-3 fatty acids in the muscle cells, but in warm water species 
such as carp and channel catfish depot fats are low in EPA and 
DHA.  They are now marketed mostly as farmed fish and the 
diets employed can somewhat alter these particulars 
 
 
 
3. Shellfish 
 
A great misunderstanding arose four decades ago.  Molluscs 
such as oysters, mussels, clams etc. are lean, lipid ranging from 
1-3% (Table 2), because their energy reserve is glycogen, not 
triacylglycerols, so there are few fatty acids.  Unfortunately the 
cells and their membranes require sterols as structural 
components.  Most have only 40% cholesterol in the sterols 
and the other 60% is made up of various algal sterols.  The 
latter are now suddenly healthy in products such as Benecol7 
and Take Control7.  However at that time methods for sterol 
analysis were poorly developed and the confusion on "the 
question to be asked" led to the 40% figure alarming 
nutritionists who must have thought that it was 40% of the total 
lipid.  Lists of food acceptable for people with elevated 
cholesterol therefore banned "shellfish".  In fact molluscs may 
have only 35-56 mg of cholesterol per 100 g sterols, or about 
the same as beef.  However lobster and crab meat have about 
75 mg/100g, and shrimp up to 150 mg/100g (Krzynowek and 
Panunzio, 1989).   
 
The fatty acid contents of shellfish muscle are also low 
because the lipid is low, and Table 2 shows that EPA is often 
higher than DHA because of the algal diet of bivalves.  The 
total available n-3 of this group is however not too dissimilar 
from that of the phospholipids of the lean fish of Table 1, or 
about 300 mg/100 g eaten.  More details of this topic will be 
found in papers by Gordon (1982) or King et al. (1990).   
Shellfish provide variety and would be more popular if safety 
was not an issue in some places.  The hazards are twofold.  
One is of course bacterial or vibrio contaminations, reflecting 
human activities and waste, and the other is toxins derived 
from algae.  The latter have recently been recognized in 
various countries around the world where they were not 
suspected before, suggesting climatic and oceanographic 
changes.  Fatty acids such as EPA (20:5n-3) in free acid form 
have in fact been suggested as factors in diarrhetic shellfish 
poisoning, but clinical evidence is scanty. 
 
 
4.  What about brain food? 
 
It is strange that about a decade ago the neurofunctional 
implications of n-3 fatty acids were catapulted into scientific 
but not necessarily public interest.  From rhesus monkeys 
(Neuringer et al, 1996) to studies on visual responses to stimuli 
in human infants (Carlson, 1997) was a considerable step.  The 
results of providing n-3 fatty acids were at times the basis of 
acrimonious disputes on methods of assessment, but a recent 
meta-analysis (San Giovanni et al 2000) concludes that in early 
development of the human visual system there are significant 
differences for DHA supplemented and DHA-free formulas.  It 
was strange that few have emphasized that the nursing infant 
receives DHA and a lesser amount of EPA in human milk, IIFET 2000 Proceedings 
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probably reflecting that available in the mother’s body 
(Ackman, 1999).  However the importance of this low level of 
DHA, found at about 0.29% of fatty acids, was masked by the 
relatively large amounts (0.5-0.7%) of arachidonic acid 
(20:4n-6), itself an important source of eicosanoids (Al et al., 
1995a). 
 
In this less than perfect world one study with fish oil showed a 
brief arresting of infant growth that was attributed to the 
competition between an excessive intake of 20:5n-3 and the 
natural level of 20:4n-6 (reviewed by many authors, for 
example Birch et al. 1998).  There is also a need to distinguish 
studies with term and pre-term infants.  Although pregnant 
women should avoid fish contaminated with heavy metals, 
pesticides, or natural toxins, the need to provide DHA to the 
infant brain in the last trimester should be an overriding 
consideration favouring fish consumption (Al et al. 1995a; 
1995b). 
 
It can be demonstrated in mice that even old mice can benefit 
from dietary DHA (Lim and Suzuki, 2000).  The problem is 
that humans are too large to be effective as experimental 
animals.  The increase in the aging population with mental 
problems suggests that something basic should be investigated 
and deficiencies in peroxisomes have been suggested in this 
connection (PØrichon and Bourre, 1996).  The reason is that 
they play a vital role in the biosynthesis of DHA.  Although 
conservation of polyunsaturated fatty acids seems an obvious 
practice the brain is difficult to investigate.  Fish consumption 
data is however available and the proportions of degenerative 
brain diseases in different situations or countries should be 
investigated. 
 
 
5.  EPA versus DHA 
 
Nobody wants to die, but it is inevitable.  The classic heart 
attack due to blocking of the coronary artery is often 
survivable with prompt treatment.  This could be called phase I 
of the exit process and can take 60 years, depending on genes 
and lifestyle.  If the genes are bad 40 years will do it.  The 
1985 Zutphen study (Kromhout et al. 1985) was the first to 
show that a cross-section of "normal" people could survive 
longer by regularly consuming fish.  The Eskimo studies of 
Bang and Dyerberg (1980) and Bang et al. (1980), supported 
by the basic research of the Burroughs Welcome Co., indicated 
that EPA (20:5n-3) was the beneficial factor.  In effect, in 
suitable subjects it helps the blood vessel walls stay elastic and 
free of deposits.  The DHA appeared to help somewhat by 
replacing some of the arachidonic acid in the blood platelets 
and thus reducing risk of clotting.  It required another decade 
before Australian scientists (Charnock et al. 1994) picked up 
on the n-3 fatty acids as factors modifying electrical problems 
leading to ventricular tachycardia (arrhythmia).  Their work 
appeared to show that this was phase II of many cardiac deaths 
but was confused at first by the use of a fish oil high in DHA.  
Later Dr. Alexander Leaf and colleagues patiently sorted out 
the movement of signals (Kang and Leaf, 1996) and showed 
that most polyunsaturated fatty acids have some beneficial 
effects.  The fact that the myocardial tissue was normally high 
in 22:6n-3 (DHA) suggests that it should have a preferential 
functional role in this situation. 
 
There are simply too many papers favourable to the clinical 
use of fish oils to review in this short article.  They provide 
both EPA and DHA in one shot, and the body actually can 
interconvert them if one is more available than the other. 
 
One company selling fish oil for use in foods has emphasized 
that in modern North America we have a shortfall of intake of 
1 g per day of EPA and DHA.  This is probably in agreement 
with the major "natural" diet studies intakes where fish were 
involved, such as the Zutphen study already cited, the U.K. 
DART study (Burr et al. 1989, Burr 1989), and with capsules 
the more recent GISSI trial (1999). 
 
 
6.  Omega-3 Fatty Acids: Is it time for clinical 
implementation? 
 
I have appropriated this heading from a short article by 
O’Keefe and Harris (2000) in the American Journal of 
Cardiology.  That is the principal decision that modern 
medicine should be making.  The problems is that a major 
pharmaceutical firm that once cheerfully sold fish oil capsules 
for 10 cents each now markets cholesterol-lowering drugs for 
several dollars for each pill.  All the major pharmaceutical 
firms sell similar products.  These products have various 
effects on HDL, LDL or other types of lipoproteins, and also 
various side-effects of uncertain importance.  While the U.S. 
National Library in Bethesda was monitoring research 
publications, they were easily able to collect annually about 
700 literature citations on fish oils and cardiovascular disease.  
From such publications views have arisen to indicate that fish 
as food and fish oils in capsules share benefits that are risk-free 
(Simopoulos, 1997).  The U.S. FDA considers that 3 g per day 
of EPA + DHA is safe.  To consume this is difficult, even with 
capsules containing 50% of these two fatty acids, but a meal of 
200 g of farmed salmon might do it.  Of course some DHA is 
available from eggs and even the white breast of chicken is an 
important source in most of the world. 
 
 
7. Conclusions 
 
Fish and shellfish provide an almost unlimited variety of fatty 
acids with beneficial role in human health.  There are no risks 
attached to these fatty acids and generally, except for deep-IIFET 2000 Proceedings 
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fried portions, they are relatively low in fat compared to many 
cuts of farm meats. 
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